USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF
Publication
, Conference
Giblin, EM; Adams, K; Mi, X; Fonarow, G; Sharma, P; Albert, N; Butler, J; DeVore, A; Duffy, C; Hernandez, A; McCague, K; Spertus, JA ...
Published in: Journal of the American College of Cardiology
March 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
March 2019
Volume
73
Issue
9
Start / End Page
836 / 836
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Giblin, E. M., Adams, K., Mi, X., Fonarow, G., Sharma, P., Albert, N., … Patterson, J. H. (2019). USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF. In Journal of the American College of Cardiology (Vol. 73, pp. 836–836). Elsevier BV. https://doi.org/10.1016/s0735-1097(19)31443-3
Giblin, Erika M., Kirkwood Adams, Xiaojuan Mi, Gregg Fonarow, Puza Sharma, Nancy Albert, Javed Butler, et al. “USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF.” In Journal of the American College of Cardiology, 73:836–836. Elsevier BV, 2019. https://doi.org/10.1016/s0735-1097(19)31443-3.
Giblin EM, Adams K, Mi X, Fonarow G, Sharma P, Albert N, et al. USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF. In: Journal of the American College of Cardiology. Elsevier BV; 2019. p. 836–836.
Giblin, Erika M., et al. “USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF.” Journal of the American College of Cardiology, vol. 73, no. 9, Elsevier BV, 2019, pp. 836–836. Crossref, doi:10.1016/s0735-1097(19)31443-3.
Giblin EM, Adams K, Mi X, Fonarow G, Sharma P, Albert N, Butler J, DeVore A, Duffy C, Hernandez A, McCague K, Spertus JA, Thomas L, Williams F, Patterson JH. USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF. Journal of the American College of Cardiology. Elsevier BV; 2019. p. 836–836.
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
March 2019
Volume
73
Issue
9
Start / End Page
836 / 836
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology